Monte Rosa Therapeutics, Inc. GLUE Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Monte Rosa Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Monte Rosa Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monte Rosa Therapeutics, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Monte Rosa Therapeutics, Inc.'s deferred tax assets and other non-current assets?
- Monte Rosa Therapeutics, Inc. (GLUE) reported deferred tax assets and other non-current assets of $832K in Q1 2026.
- How has Monte Rosa Therapeutics, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Monte Rosa Therapeutics, Inc.'s deferred tax assets and other non-current assets increased by 89.1% year-over-year, from $440K to $832K.